121 related articles for article (PubMed ID: 2568935)
21. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
Mattsson H; Hedberg A; Carlsson E
J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
[TBL] [Abstract][Full Text] [Related]
22. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
Fitzgerald DE; Harry JD
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
[TBL] [Abstract][Full Text] [Related]
23. beta 1-and beta 2-adrenoceptor stimulatory effects of prenalterol.
Mattsson H; Andersson T; Carlsson E; Hedberg A; Lundgren B; Olsson T
Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):302-8. PubMed ID: 6132344
[TBL] [Abstract][Full Text] [Related]
24. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.
Brodde OE; Daul A; Michel-Reher M; Boomsma F; Man in 't Veld AJ; Schlieper P; Michel MC
Circulation; 1990 Mar; 81(3):914-21. PubMed ID: 1968366
[TBL] [Abstract][Full Text] [Related]
25. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
Tesfamariam B; Allen GT
Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
[TBL] [Abstract][Full Text] [Related]
26. In vitro evidence that carteolol is a nonconventional partial agonist of guinea pig cardiac beta1-adrenoceptors: a comparison with xamoterol.
Floreani M; Froldi G; Quintieri L; Varani K; Borea PA; Dorigo MT; Dorigo P
J Pharmacol Exp Ther; 2005 Dec; 315(3):1386-95. PubMed ID: 16160085
[TBL] [Abstract][Full Text] [Related]
27. Relevance of intrinsic sympathomimetic activity for beta blockers.
Jaillon P
Am J Cardiol; 1990 Sep; 66(9):21C-23C. PubMed ID: 1977302
[TBL] [Abstract][Full Text] [Related]
28. Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function.
Rousseau MF; Pouleur H; Debaisieux JC; Van Eyll C; Charlier AA
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):84S-85S. PubMed ID: 2572264
[TBL] [Abstract][Full Text] [Related]
29. Potent inhibition of spontaneous rhythmic contraction by a novel beta 2-adrenoceptor agonist, HSR-81, in pregnant rat uterus.
Ohashi T; Hashimoto S; Morikawa K; Kato H; Ito Y; Asano M; Azuma H
Eur J Pharmacol; 1996 Jul; 307(3):315-22. PubMed ID: 8836620
[TBL] [Abstract][Full Text] [Related]
30. Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.
Baker JG; Kemp P; March J; Fretwell L; Hill SJ; Gardiner SM
FASEB J; 2011 Dec; 25(12):4486-97. PubMed ID: 21865315
[TBL] [Abstract][Full Text] [Related]
31. Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.
Tomlinson B; Cruickshank JM; Hayes Y; Renondin JC; Lui JB; Graham BR; Jones A; Lewis AD; Prichard BN
Br J Clin Pharmacol; 1990 Nov; 30(5):665-72. PubMed ID: 1980200
[TBL] [Abstract][Full Text] [Related]
32. Inverse agonist activities of beta-adrenoceptor antagonists in rat myocardium.
Varma DR; Shen H; Deng XF; Peri KG; Chemtob S; Mulay S
Br J Pharmacol; 1999 Jun; 127(4):895-902. PubMed ID: 10433496
[TBL] [Abstract][Full Text] [Related]
33. The affinity and efficacy of the selective beta 1-adrenoceptor stimulant RO363 at beta 1- and beta 2-adrenoceptor sites.
McPherson GA; Malta E; Molenaar P; Raper C
Br J Pharmacol; 1984 Aug; 82(4):897-904. PubMed ID: 6148117
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological characteristics of BDTI, a new isoquinoline-derived beta 2-adrenoceptor agonist, in canine trachea and rat heart.
Lin CH; Yang CM; Chen CM; Ko FN; Teng CM
Pharmacology; 1996 Jul; 53(1):19-27. PubMed ID: 8875598
[TBL] [Abstract][Full Text] [Related]
35. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
[TBL] [Abstract][Full Text] [Related]
36. Bucindolol displays intrinsic sympathomimetic activity in human myocardium.
Andreka P; Aiyar N; Olson LC; Wei JQ; Turner MS; Webster KA; Ohlstein EH; Bishopric NH
Circulation; 2002 May; 105(20):2429-34. PubMed ID: 12021232
[TBL] [Abstract][Full Text] [Related]
37. Selectivity of xamoterol, prenalterol and salbutamol as assessed by their effects in the presence and absence of ICI 118 551.
McCaffrey PM; Riddell JG; Shanks RG
Eur Heart J; 1990 Apr; 11 Suppl A():54-5. PubMed ID: 1971592
[TBL] [Abstract][Full Text] [Related]
38. Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline.
Gibbons DO; Lant AF; Ashford A; Collins RF; Pinder S
Br J Clin Pharmacol; 1976 Feb; 3(1):177-84. PubMed ID: 973938
[TBL] [Abstract][Full Text] [Related]
39. Influence of receptor reserve on beta-adrenoceptor-mediated responses in human lung mast cells.
Drury DE; Chong LK; Ghahramani P; Peachell PT
Br J Pharmacol; 1998 Jun; 124(4):711-8. PubMed ID: 9690863
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of RO363, a beta1-adrenoceptor selective agonist.
Iakovidis D; Malta E; McPherson GA; Raper C
Br J Pharmacol; 1980 Apr; 68(4):677-85. PubMed ID: 6103722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
